PRs are one of the most cost effective marketing tools online! Signup Today!

Blog

Phase 1 Clinical Trial Results Using Satipharm Capsules Published …

Posted by on 3:30 am in Press Release | 0 comments

VANCOUVER, British Columbia, Nov. 16, 2017 (GLOBE NEWSWIRE) — Harvest One Cannabis Inc. (TSX-V:HVST) (“Harvest One“) through its wholly owned Swiss Subsidiary Satipharm AG (“Satipharm“) is pleased to advise that results from the Phase 1 Clinical Trial undertaken by PhytoTech Therapeutics (“PTL“) in Israel using Satipharm’s proprietary GelpellR technology have been published.

The article “Single-Dose Pharmacokinetics of Oral Cannabidiol Following Administration of PTL101: A New Formulation Based on Gelatin Matrix Pellets Technology” has been published in Clinical Pharmacology in Drug Development (“CPDD”). 

The PTL101 drug beads utilise a proprietary formulation developed through Satipharm’s Gelpell-CBD™ product technology, which contain organically derived, highly purified CBD.

Established in 2012, CPDD is an international, peer-reviewed publication and the official journal of the American College of Clinical Pharmacology, providing a forum for the presentation of first-time-in-man study results. CPDD publishes high-quality clinical pharmacology studies in drug development which are primarily (but not exclusively) performed in early development phases in healthy subjects. 

PTL completed its Phase 1 Clinical Trial of the PTL101 capsules in March 2016, with results demonstrating the safety and high performance of the oral capsule technology, including the effective delivery profile of cannabidiol (“CBD”) compound to trial subjects.

The Phase 1 Clinical Trial also highlighted the favourable bioavailability of the capsules in comparison to Sativex – a market-leading, commercially available cannabinoid oral spray produced by GW Pharmaceuticals.

Phase 2 Clinical Trial Update

PTL has since commenced its Phase 2 Clinical Trial into the efficacy of the PTL101 capsules in treating refractory epilepsy in children.

The completion of this Phase 2 Clinical Trial would be a major catalyst towards the commercial development of the PTL101 capsules, with PTL potentially only the third company behind GW Pharmaceuticals and Insys Therapeutics Inc. to present results of a formal Phase 2 Clinical Trial into refractory epilepsy in children.

In addition, a Phase 2 Clinical Trial into the safety and efficacy of PTL201 capsules in treating spasticity related symptoms of multiple sclerosis (“MS”) patients is planned to commence in due course.

About Harvest One

Harvest One Cannabis Inc. (TSXV: HVST) controls operations across the entire cannabis value chain through three business units, with Harvest One serving as the umbrella company over horticultural arm United Greeneries and medical arm Satipharm AG. Each business is strategically located in favourable jurisdictions with supportive regulatory frameworks in place. United Greeneries has received a Canadian medicinal cannabis cultivation and sales license, making Harvest One one of only a few companies globally with the capacity to commercially cultivate and sell cannabis in a federally regulated environment.

For more information on Harvest One Cannabis, please contact:

Colin Clancy
Investor Relations
+ 1 (877) 915 7934
cclancy@mmj.ca

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. The forward-looking information contained in this press release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.

Man Charged with Threatening to Shoot Several People

Posted by on 3:30 am in Press Release | 0 comments

The Cleveland Division of the FBI, the United States Attorney’s Office, Northern District, and the Cuyahoga Falls Police Department announce the arrest of a Cuyahoga Falls man charged with interstate threatening communications and destruction of evidence. 

Wei Li, age 28, texted his estranged wife on November 6, 2017 multiple times threatening to kill her and to shoot up a Las Vegas hotel and casino. Li also referenced conducting a mass shooting at a church with at least 1,000 people in attendance. Li indicated in the text messaging that the killing he planned to commit would go down in history and that he would blame his wife for all the deaths. Li’s wife was employed at a Las Vegas casino at the time of the text. 

On November 10, 2017, during a joint interview with FBI agents and Cuyahoga Falls Police Detectives, Li was asked to unlock his phone, he complied but proceeded to delete a string of text messages. Li was immediately arrested and placed in local custody. 

This morning, November 16, 2017, Li was transferred into federal custody. He will have his initial appearance in U.S. Magistrate Judge George Limbert’s courtroom today, Thursday, November 16, 2017, at 9 a.m. 

A complaint is only a charge and is not evidence of guilt. The defendant is entitled to a fair trial in which it will be the government’s burden to prove guilt beyond a reasonable doubt. 

Any questions regarding this news release can be directed to SA Vicki D Anderson at the Cleveland Office of the FBI, 216-522-1400 or Vicki.Anderson@ic.fbi.gov.

Titanic Returns to the Big Screen for 20-Year Anniversary in Exclusive Dolby Cinema at AMC Engagement

Posted by on 2:15 am in Press Release | 0 comments

SAN FRANCISCO, Nov. 15, 2017 (GLOBE NEWSWIRE) — Dolby Laboratories, Inc. (NYSE:DLB), Paramount Pictures, and AMC Theatres® (NYSE:AMC) today announced that Titanic, winner of 11 Academy Awards including Best Picture and Best Director, will return to select theaters nationwide for an exclusive one-week engagement in Dolby Cinema at AMC. In celebration of the film’s 20-year anniversary, audiences across the U.S. can experience Paramount Pictures and Twentieth Century Fox’s Titanic in all Dolby Cinema at AMC locations, including 20 locations supporting 3D, beginning December 1, 2017.

A photo accompanying this announcement is available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/8f31cb1e-b193-456f-97e3-87c6c99f7642

This marks the first-ever release of Titanic in Dolby Vision in 2D and 3D, a direct result of ongoing partnerships with both James Cameron and Paramount Pictures.

“We mastered a few minutes of Titanic in Dolby Vision and I was stunned. It was like seeing it for the first time. Now that the entire film has been mastered, I’m excited to share it with audiences across the U.S.,” said filmmaker and director James Cameron. “This is beyond 3D, beyond 70mm, it’s beyond anything you’ve seen before. The image leaps off the screen as bright and vibrant as life itself. This is the way all movies should be seen and without a doubt, Titanic has NEVER looked better.”

“James Cameron shares our vision for creating the world’s best cinematic experiences,” said Doug Darrow, Senior Vice President, Cinema Business Group, Dolby Laboratories. “Our partnership with James and Paramount Pictures has enabled us to showcase a masterpiece of theater in the most incredible way, leveraging Dolby Vision to breathe new life into one of the most awarded films in the history of cinema. Titanic at Dolby Cinema is truly a can’t-miss experience.”

“This timeless love story makes the perfect romantic date – or fun night out with friends,” said Elizabeth Frank, EVP Global Programming and Chief Content Officer, AMC. “Twenty years since it first played in theatres, Titanic in Dolby Cinema at AMC will captivate movie fans like never before.”

A premium cinema offering for moviegoers, Dolby Cinema begins with the filmmakers’ vision—using the full storytelling capabilities that Dolby offers in image and sound production to transform the way movies are made and presented. With state-of-the-art image, sound, and acoustic capabilities, the movie comes alive to deliver cinema in its purest form. The Dolby Vision projection system, which uses state-of-the-art optics and image processing, delivers high dynamic range with enhanced color technology and a contrast ratio that far exceeds that of any other image technology on the market today. Dolby Cinema also includes the award-winning Dolby sound technology Dolby Atmos, which moves audio around the cinema, even overhead, placing the audience deeper inside the film’s setting.

Guests at Dolby Cinema at AMC also enjoy the incredible comfort of the AMC Signature Recliners that pulsate with the action on screen.

Moviegoers can purchase tickets to the exclusive engagement beginning November 15, 2017 at 5:30am PST through Dolby Cinema at AMC locations and online at www.amctheatres.com/titanic, with each Titanic ticket transaction including a free digital movie download of Titanic redeemable at paramountmovies.com while supplies last.

About Dolby Laboratories
Dolby Laboratories creates audio, video, and voice technologies that transform entertainment and communications in mobile devices, at the cinema, at home, and at work. For more than 50 years, sight and sound experiences have become more vibrant, clear, and powerful in Dolby. For more information, please visit www.dolby.com.    

About Paramount Pictures Corporation
Paramount Pictures Corporation (PPC), a global producer and distributor of filmed entertainment, is a unit of Viacom (NASDAQ:VIAB) (NASDAQ:VIA), a leading content company with prominent and respected film, television and digital entertainment brands. Paramount controls a collection of some of the most powerful brands in filmed entertainment, including Paramount Pictures, Paramount Animation, Paramount Television, Paramount Players, MTV Films, and Nickelodeon Movies. PPC operations also include Paramount Home Media Distribution, Paramount Pictures International, Paramount Licensing Inc., and Paramount Studio Group.

About Twentieth Century Fox Film
One of the world’s largest producers and distributors of motion pictures, Twentieth Century Fox Film produces, acquires and distributes motion pictures throughout the world.  These motion pictures are produced or acquired by the following units of Twentieth Century Fox Film: Twentieth Century Fox, Fox 2000 Pictures, Fox Searchlight Pictures, Fox International Productions, Twentieth Century Fox Animation and Fox Family.

About AMC Entertainment Holdings, Inc.   
AMC is the largest movie exhibition company in the U.S., in Europe and throughout the world with approximately 1,000 theatres and 11,000 screens across the globe. AMC has propelled innovation in the exhibition industry by: deploying more plush power-recliner seats; delivering enhanced food and beverage choices; generating greater guest engagement through its loyalty program, web site and smart phone apps; offering premium large format experiences and playing a wide variety of content including the latest Hollywood releases and independent programming. AMC operates among the most productive theatres in the United States’ top markets, having the #1 or #2 market share positions in 22 of the 25 largest metropolitan areas of the United States, including the top three markets (NY, LA, Chicago). Through its Odeon subsidiary AMC operates in 14 European countries and is the # 1 theatre chain in UK Ireland, Italy, Spain, Sweden, Finland and the Baltic States. www.amctheatres.com.

Dolby, Dolby Atmos, and the double-D symbol are registered trademarks of Dolby Laboratories. All other trademarks remain the property of their respective owners.

Media Contact

Darren Murph, +1-415-357-7043
Darren.Murph@dolby.com

CanniMed Acknowledges Aurora Press Release and Announces Exclusivity Agreement and Intention to Acquire …

Posted by on 2:15 am in Press Release | 0 comments

SASKATOON, Saskatchewan–(BUSINESS WIRE)–CanniMed Therapeutics Inc. (“CanniMed”) (TSX: CMED) acknowledges
the press release of Aurora Cannabis Inc. (“Aurora”) with respect
to the announcement of its intention to make an unsolicited offer (the “Unsolicited
Offer”
) for all of the common shares of CanniMed on the basis
of a certain number of Aurora common shares for each common share of
CanniMed based on an exchange ratio (the “Exchange Ratio”) noted in the
Aurora press release.

We advise shareholders to take NO action until such time as the Board
has had the opportunity to fully consider and make a recommendation
regarding the Unsolicited Offer
.

At this time, the Board has not received a formal written offer from
Aurora. CanniMed notes that the Unsolicited Offer is speculative as the
Aurora press release cautions that Aurora may determine not to proceed
with its proposal in the circumstances described in the Aurora press
release. Further, CanniMed cautions that the share consideration (or
equivalent share value) offered by Aurora in its press release is
inflated and CanniMed believes over values Aurora in that it is based on
the closing price of the Aurora shares on the TSX on November 14, 2017,
which reflects an increase of 124.9% over Aurora’s closing price on the
TSX over the preceding 12 trading days (Aurora’s closing share price on
October 27th, before the recent run-up, was $2.85 which
implies a value of $12.90 per CanniMed share at the Exchange Ratio.
CanniMed’s closing price on October 27th was $11.53).

The Board, in consultation with its financial and legal advisors intends
to review the terms set out in the Aurora press release and will
communicate further to shareholders as soon as practical and in any
event no later than the end of day Friday, November 17, 2017. Further,
the Board will provide a formal recommendation to its shareholders in
the event that a formal offer is provided.

CanniMed also announces that it has previously entered into an
exclusivity agreement with, and is in advanced discussions to acquire,
Newstrike Resources Ltd. (TSXV: HIP) (“Newstrike”) at an exchange
ratio of 0.033 CanniMed shares per Newstrike share, a transaction that
if completed would be expected to provide CanniMed with accelerated
penetration into the adult use cannabis market. Newstrike has a leading
recreational brand, “Up Cannabis”, and a partnership with the Canadian
musical artists, The Tragically Hip. Any transaction with Newstrike is
expected to be subject to, among other things, the approval of
shareholders of CanniMed and Newstrike at special meetings of
shareholders called for that purpose, and regulatory and court approval.
There is, however, no certainty that any transaction with Newstrike will
be entered into or completed.

Further details will be provided to shareholders as soon as practical
and shareholders are again cautioned to take no action.

Shareholders with questions should call CanniMed’s strategic
shareholder services advisor, Kingsdale Advisors, at 1-888-518-1554.

About CanniMed Therapeutics Inc.
CanniMed is a
Canadian-based, international plant biopharmaceutical company and a
leader in the Canadian medical cannabis industry, with 16 years of
pharmaceutical cannabis cultivation experience, state-of-the-art,
GMP-compliant production process and world class research and
development platforms with a wide range of pharmaceutical-grade cannabis
products. In addition, the Company has an active plant biotechnology
research and product development program focused on the production of
plant-based materials for pharmaceutical, agricultural and environmental
applications.

The Company, through its subsidiaries, was the first producer to be
licensed under the Marihuana for Medical Purposes Regulations,
the predecessor to the current Access to Cannabis for Medical
Purposes Regulations
. It was the sole supplier to Health Canada
under the former medical marijuana system for 13 years, and has been
producing safe and consistent medical marijuana for thousands of
Canadian patients, with no incident of product diversion or recalls.

For more information, please visit our websites: www.cannimed.ca
(patients) and www.cannimedtherapeutics.com
(investors).

Forward Looking Statements
This release includes
certain statements that are deemed forward looking statements or forward
looking information within applicable Canadian securities laws. All
statements in this release, other than statements of historical facts,
that address events or developments that the Company expects to occur,
are forward-looking statement or information. Forward looking statements
and information are statements that are not historical facts and are
generally, but not always, identified by the words expects, plans,
anticipates, believes, intends, estimates, projects, potential and
similar expressions, or that events or conditions will, would, may,
could or should occur, and include statements with respect to a possible
offer for the common shares, expected accretive transaction and proposed
acquisition of Newstrike. Although the Company believes the expectations
expressed in such forward looking statements and information are based
on reasonable assumptions, such statements are not guarantees of future
performance and actual results may differ materially from those in the
forward looking statements. Factors that could cause the actual results
to differ materially from those in forward looking statements include:
uncertainty that an offer will be made, uncertainty that an accretive
transaction will be announced, uncertainty that a definitive agreement
with Newstrike will be approved by the Board, and uncertainty as to the
Board’s recommendation in respect of a possible offer and the timing
thereof. Investors are cautioned that any such statements are not
guarantees of future performance and actual results or developments may
differ materially from those projected in the forward looking statements
and information. Forward looking statements and information are based on
the beliefs, estimates and opinions of the Company’s management on the
date the statements are made. Except as required by applicable
securities laws, the Company undertakes no obligation to update these
forward looking statements in the event that managements beliefs,
estimates or opinions, or other factors, should change.

Pioneer Natural Resources Announces Fourth Quarter 2017 Earnings News Release Date and Conference Call

Posted by on 1:28 am in Press Release | 0 comments

DALLAS–(BUSINESS WIRE)–Pioneer Natural Resources Company (“Pioneer”) (NYSE:PXD) today
announced its fourth quarter 2017 earnings news release is scheduled to
be issued after the close of trading on the New York Stock Exchange on
Tuesday, February 6, 2018.

A conference call is scheduled for Wednesday, February 7, 2018, at 9:00
a.m. CST to discuss the fourth quarter results. Instructions on how to
listen to the call and view the accompanying presentation are shown
below.

Internet: www.pxd.com
Select
“Investors” then “Earnings Webcasts” to listen to the discussion and
view the presentation.

Telephone: Dial (866) 564-2842, confirmation code 1440973 five minutes
before the call. View the presentation via Pioneer’s internet address
above.

A replay of the webcast will be archived on Pioneer’s website. A
telephone replay will be available through March 04, 2018. To register
for the call-in audio replay click
here
and enter confirmation code 1440973.

Pioneer is a large independent oil and gas exploration and production
company, headquartered in Dallas, Texas, with operations in the United
States. For more information, visit Pioneer’s website at www.pxd.com.

Amended News Release – Namaste Expands Brazilian Market and Acquires Leading Vaporizer Retailer

Posted by on 1:28 am in Press Release | 0 comments

VANCOUVER, British Columbia, Nov. 14, 2017 (GLOBE NEWSWIRE) — Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRANKFURT:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that it has acquired the domain and customer database of Brazil’s largest vaporizer retailer, vaptvupt.lojaintegrada.com.br (“VapeBr”), in consideration of signing an exclusive services agreement for fulfillment (the “Agreement”) for Namaste’s Brazilian operations. There was no cash consideration for the acquisition. Based on VapeBr’s 90-day sales history with monthly sales over CAD $80,000 per month (with 30% average margin) and through implementation of Namaste’s SEO and machine learning algorithms, the Company expects to add over CAD $1M in additional annual revenue to Namaste’s current revenue stream. Namaste believes that with the acquisition of VapeBR and with establishing a local fulfilment center, that its Brazilian operations will be profitable immediately.

Under the terms of the Agreement, Namaste has acquired the VapeBr domain and will therefore inherit all future associated revenue, in exchange for an exclusive fulfillment services agreement. VapeBr management will receive a USD$20.00 fulfilment fee for each order fulfilled and has agreed to provide the following services:

  • Inventory management: maintaining stock on behalf of Namaste, keeping accurate stock counts, monitoring for fraudulent orders and managing chargebacks, providing forecasts for future inventory purchasing.
  • Order processing: receiving orders electronically, picking, packing and processing orders to ship to Namaste and VapeBR customers.
  • Local support: local sales and customer service, managing tickets, live chat.
  • Warranty/Return Processing: receiving faulty items and issuing replacements under warranty.

Namaste has also agreed to work with the VapeBr management team to solicit top brands in order to provide local warranty and repair services for the Brazilian market. Many of the top brands do not have local facilities and Namaste believes that in working VapeBr management, it can provide added value to these brands in the quickly emerging Brazilian market.

As a result of this transaction, Namaste plans to greatly expand the VapeBr product offering, as it sees very strong growth potential in the Brazilian market. The acquisition of the VapeBr e-commerce platform is not only expected to have an immediate impact on Namaste’s revenue, but it is also expected to add over 10,000 additional customers to Namaste’s growing global database of medical cannabis users. Through the integration of VapeBr onto Namaste’s proven e-commerce platform, Namaste is confident it can substantially grow this already impressive customer base. This Agreement further validates Namaste’s ability to consolidate industry competitors and expand its operations abroad.

Additionally, Namaste is pleased to announce that the NamasteMD smartphone app has been submitted to the Apple Store, is awaiting approval, and is expected to soon be available on both IOS and Android devices. NamasteMD is a revolutionary telemedicine application which has been designed to connect patients with doctors and nurse practitioners, in an attempt to facilitate a seamless process for obtaining medical documents under Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”) program. This state of the art application incorporates facial recognition algorithms, and is the first of its kind to feature exclusive age and identity verification technology. Namaste plans on utilizing this technology on the NamasteMD platform to distribute medicinal cannabis through its wholly owned subsidiary, Cannmart Inc.

Management Commentary

Sean Dollinger, President and CEO of Namaste comments:  “I am extremely proud of our team for building an e-commerce platform that is being actively solicited by our direct competitors to work collaboratively. Based on this agreement, we expect further opportunities to present themselves for Namaste to work with companies looking to divest their businesses, and believe such arrangements are a win-win situation for all parties involved. We are extremely excited that our efforts are not only being noticed but rewarded with arrangements as such. Namaste welcomes these opportunities and anticipates these trends to continue as Namaste steals market share on a global scale. This transaction further confirms the value we have created with regards to the products and services we provide, and our ability to leverage our database moving forward.

As our e-commerce platform evolves, we are confident our decision to implement cutting edge age and identity verification technology ahead of our competition will be instrumental in allowing us to become industry leaders. We believe these innovative initiatives not only demonstrate our commitment to the industry, but also provide an ideal solution to ensure the safe and responsible distribution of recreational cannabis on both a provincial and federal level.”

About Namaste Technologies Inc.
Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, US, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Board of Directors

“Sean Dollinger”
Chief Executive Officer
+1 (786) 389 9771
Email: Sean@NamasteTechnologies.com  

Further information on the Company and its products can be accessed through the links below:
www.namastetechnologies.com
www.namastevaporizers.com
www.namastevaporizers.co.uk
www.everyonedoesit.com
www.everyonedoesit.co.uk

FORWARD LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

PRESS RELEASE: Auto show will be the first chance to take a peek inside the expanding Moscone Center

Posted by on 12:55 am in Press Release | 0 comments

http://www.sfgate.com/local/article/PRESS-RELEASE-Auto-show-will-be-the-first-chance-12353974.php

  • The metal canopy above the third floor at the Moscone Center South as construction continues on Thursday, Sept. 7, 2017, in San Francisco. Photo: Santiago Mejia, The Chronicle

Caption

Close



















(Press Release) Moscone Convention Center has risen to new heights this year.

The expanded South Hall, now 108 feet tall and 255 feet long, was officially opened when Mayor Ed Lee, Supervisor Jane Kim and Board of Supervisors President London Breed cut the ribbon on Sept. 11, 2017, but the first opportunity for the general public to get inside the addition is the San Francisco International Auto Show, which opens Nov. 18.

“The San Francisco Auto Show will be the first opportunity to take a peek inside the expanding Moscone Center,” said Joe D’Alessandro, president and chief executive officer of San Francisco Travel. “Although the entire building won’t open until January of 2019, this year’s auto show will give the public the chance to see what the beautiful new building will look like.”

The partnerships with the city and convention center began with the 1982 auto show, which introduced the general public to the new South Hall and was cemented when the public was introduced to the North Hall at the 1992 show.


San Francisco Mayor Ed Lee cut the ribbon on the completion of the half billion dollar plus Phase 2 of the newly refurbished and greatly expanded Moscone Center.


Media: KTVU


“The auto show is the only event at Moscone Center that invites the entire Bay Area to enjoy the complex,” said Building Manager Bob Sauter. “And it is a great show.”

More than 200,000 square feet have been added to the South Hall with the completion of Phase Two of the expansion project.

Access between the North and South Halls are underground. The North Hall is the only entrance to the auto show.

Test Drives, one of the most popular features of the auto show, will be located on Howard St., at the front of both halls.

Major manufacturers 2018 models will be displayed in the South Hall, sharing space with classic cars from the San Francisco Academy of Arts University collection and an exhibit by Pacific Gas and Electric. Ferrari and Aston Martin clubs will also be located in the South Hall.

The North Hall will feature manufacturer displays as well as exhibits by: the San Francisco Chronicle and Golden1 Credit Union.


A new entrance to the Esplanade Ballroom above and behind the South Hall is part of the recently competed expansion.

Modified vehicles have been exhibited in the San Francisco Auto Salon located in the Esplanade Ballroom, under the guidance of John Liwanag, since the exhibit outgrew the After-Market Alley.

“Our plan was to give a younger demographic something special they would relate to, different from the manufacturers’ production vehicles or the Academy of Art exhibit of beautiful classic cars,” said Scott Diamond, assistant show manager.

The center was named for late Mayor George Moscone, who successfully shepherded the project through a successful vote of the people. The center is owned by the City and County of San Francisco—the taxpayers.

From its modest beginning, the center has stood the test of time, with still more to come. The final phase of construction is expected to be finished in December 2018.

“We have held our show at the Moscone Center since it was just a hole in the ground,” said Kevin Diamond, auto show director. “It just gets better and better.” 

The San Francisco Chronicle 60th Annual International Auto Show opens Saturday, Nov. 18 and runs through the Thanksgiving weekend concluding on Sunday, Nov. 26, 2017 at Moscone Convention Center.

The show is presented by Golden1 Credit Union and supported by the California New Car Dealers Association. It will feature the 2018 model cars, trucks, SUV’s and crossover vehicles representing the work of 37 global manufacturers. The San Francisco Auto Show is the Bay Area’s largest and most prestigious auto exposition and is the only auto show held regionally that lures the dazzling high-tech manufacturer displays.

Press Release: Interception of Drugs in Parham

Posted by on 11:20 pm in Press Release | 0 comments

On Friday 10th November, 2017, the ONDCP conducted a successful drug interdiction operation in the Parham area during which a quantity of Cannabis and Cash, (US and Eastern Caribbean currency) were retrieved.

The Cannabis weighs a total of 229lbs 1oz and carries an estimated wholesale value of Nine Hundred and Sixteen Thousand, Two Hundred and Fifty Dollars ($916,250.00 ECD) and cash which amounted to One Thousand, One hundred and Seven US Dollars ($1,107.00) and Thirty – Seven Thousand, Seven Hundred and Thirty-Six Dollars and Seven cents EC ($37,736.07 ECD).

Three males and one female were detained in this matter and investigations are ongoing.

 

Press Release: Multiple Drug Arrests

Posted by on 11:20 pm in Press Release | 0 comments

Several people are in police custody and are likely to be charged, following a number of intelligence driven operations, which resulted in the seizure of large quantities of controlled drugs and ammunition.

On Friday, a team of police officers from the Criminal Investigations Department, Narcotics and K-9 Unit conducted a raid on a Cashew Hill property and found 307 grams of Cannabis. Three men, namely Dequain Peters, Kimani Gardner and Dujon Nugent were found on the property and were arrested and taken into custody. The police also carried out searches on two separate abandoned buildings in the area and found 9 ½ pounds of Cannabis in one and an additional 205 grams in the other. The drugs were seized and taken to the police station.



The searches continued at St. Johnsons Village, in an area commonly referred to as “Mad People Town,” where Saran Andre was found with 159.5 grams of Cannabis in his possession. The drugs were found wrapped in 106 transparent plastic bags. A further search was conducted on a vacant parcel of land in the area, and the police found 1 ¾ pounds of Cannabis and eleven rounds of 9mm ammunition. The items were seized and taken to the police station. Further
investigations are currently on-going.

Fraser Institute News Release: More Quebec high schools improving than declining in student performance

Posted by on 10:32 pm in Press Release | 0 comments

MONTREAL, QC–(Marketwired – November 11, 2017) – There are more high schools in Quebec showing signs of student improvement than schools on the decline, according to the Fraser Institute’s annual school ranking released today.

The Report Card on Quebec’s Secondary Schools 2017 ranks 455 public, private, francophone and anglophone schools based largely on results from provincewide tests in French, English, science, mathematics and history.

In this year’s ranking, 57 schools showed statistically significant improvement, compared to 46 schools with declining performance.

“No type of school — and no one city — has a monopoly on improvement — different types of schools all over Quebec serving students with different personal characteristics have found ways to improve year-over-year,” said Yanick Labrie, Fraser Institute Senior Fellow.

The schools that improved over the past four years include public and independent schools, as well as English and French schools.

And they are located across the province including in Montreal, Sherbrooke, Quebec City, Baie-Comeau, Saguenay and Saint-Jerome, which has four high schools with improving scores.

In fact, seven high schools operated by the Commission scolaire de la Riviere-du-Nord in the Laurentian Mountains north of Montreal — which includes Saint-Jerome — have improved their ratings in the past four years.

“We don’t know why so many of the schools in this one board are improving, but finding out should be a top priority for the Ministry of Education so that the lessons learned can be exported elsewhere in the province,” Labrie said.

Detailed results of all 455 schools can be found at www.compareschoolrankings.org.

MEDIA CONTACT:
Yanick Labrie, Senior Fellow
Fraser Institute
communications@fraserinstitute.org

To arrange media interviews or for more information, please contact:
Bryn Weese
Media Relations Specialist
Fraser Institute
(604) 688-0221 ext. 589
bryn.weese@fraserinstitute.org

Follow the Fraser Institute on Twitter and Facebook

The Fraser Institute is an independent Canadian public policy research and educational organization with offices in Vancouver, Calgary, Toronto, and Montreal and ties to a global network of think-tanks in 87 countries. Its mission is to improve the quality of life for Canadians, their families and future generations by studying, measuring and broadly communicating the effects of government policies, entrepreneurship and choice on their well-being. To protect the Institute’s independence, it does not accept grants from governments or contracts for research. Visit www.fraserinstitute.org